Mirum Pharmaceuticals, Inc. — Director's Dealing 2021

Nov 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-11-24

Reporting Person: Peetz Christopher (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-24	Common Stock	P	7000	$14.40	Acquired	28027	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	201570	Indirect

Footnotes

F1: The Reporting Person's purchase of MIRM common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 3,672 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transaction resulted in short-swing profits of $17,831.23 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.